Delivery Order SPE2DB22D9205-SPE2DB24FZF77
- Not listed
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency to provide Xolair 150 mg/1.2 ml powder vials. The $15,474 delivery order has a completion date of December 29, 2023 and was awarded on December 7, 2023. DMS Pharmaceutical Group will deliver the pharmaceutical items to the Park Ridge, Illinois location of the Defense Logistics Agency Troop Support Medical. As a woman-owned small business, DMS...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at eleven thousand six hundred five dollars and fifty cents ($11,605.50) by the Defense Logistics Agency. This order was issued against DMS Pharmaceutical Group's indefinite delivery contract to supply pharmaceutical items and medical products to the Defense Logistics Agency with a potential value of up to five million dollars through December 2025. Under this order, DMS Pharmaceutical Group will deliver...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $9,284.40 by the Defense Logistics Agency Troop Support Medical to provide Xolair 150 mg/ml syringes. This delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency, which has a potential value of up to $5 million through December 2025 to supply needed pharmaceutical items and medical products to military treatment centers supported by the...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $6,189.60 by the Defense Logistics Agency to provide Xolair 150 mg/ml syringes. The delivery order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency to supply various pharmaceutical items and medical supplies with a potential value of up to $5 million through December 2025. No set-aside designation was applied to this delivery order....
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at twenty-seven thousand eight hundred fifty-three dollars and twenty cents ($27,853.20) by the Defense Logistics Agency to supply Xolair 150 mg/1.2 ml powder vials. The delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to provide pharmaceuticals and medical supplies with a potential value of up to five million dollars through...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $23,984.70 under an indefinite delivery contract with the Defense Logistics Agency to supply XOLAIR 150MG/ML SYR 1S. The delivery order has a completion date of December 12, 2023 and was awarded on the same date by the Defense Logistics Agency Troop Support Medical. DMS Pharmaceutical Group Inc. will fulfill the delivery order from its location in Park Ridge, Illinois. As a woman-owned small business and...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at thirty-seven thousand one hundred thirty-seven dollars and sixty cents ($37,137.60) by the Defense Logistics Agency to supply XOLAIR 150 MG/1.2 ML POWDER VLS. The place of performance is Park Ridge, Illinois and the completion date is December 7, 2023. DMS Pharmaceutical Group holds an indefinite delivery contract with the Defense Logistics Agency, with a potential value of up to five million dollars...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency to provide Xolair 150 mg/1.2 ml powder vials. The $18,568.80 order has a completion date of December 18, 2023 and was awarded on November 27, 2023. DMS Pharmaceutical Group will fulfill the order as the prime vendor, supplying the pharmaceutical item to DLA Troop Support Medical facilities from its location in Park Ridge, Illinois. As a...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $77,370 under an indefinite delivery contract with the Defense Logistics Agency to supply XOLAIR 150 MG/ML SYRINGEML. As a woman owned small business and woman owned business, DMS Pharmaceutical Group will deliver the pharmaceutical products to Park Ridge, Illinois by December 2023. DMS Pharmaceutical Group currently supplies various medical supplies and pharmaceuticals to support military treatment facilities...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at ten thousand eight hundred thirty-one dollars and eighty cents ($10,831.80) by the Defense Logistics Agency to supply XOLAIR 150 MG/ML SYRINGEML. The delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to provide pharmaceuticals and medical supplies with a potential value of up to five million dollars through December 2025. No...
- SPE2DB22D9205Indefinite Delivery Contract
- SPE2DB22D9205-SPE2DB24FZF77Delivery Order
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at eleven thousand six hundred five dollars and fifty cents ($11,605.50) by the Defense Logistics Agency to provide Xolair 150 mg/1.2 ml powder vials. The delivery order was issued on December 5, 2023 against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to supply pharmaceuticals and medical supplies with a potential value of up to five million dollars through December 2025. Performance is required to be completed by December 27, 2023. The delivery order does not contain any set aside designations and was awarded competitively. DMS Pharmaceutical Group will fulfill the delivery order through its operations in Park Ridge, Illinois as a woman-owned small business supporting the medical product needs of Defense Logistics Agency Troop Support worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.6k | 12/5/23 |